Health

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...

2021-03-05 04:01 107

Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States

TAIPEI, March 4, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") announced today that it has entered into an exclusive license agreement with Intas Pharmaceuticals ("Intas") for the US commercialization of Foresee's novel FP-001 program, Leuprolide Mesylate Injectable Suspensi...

2021-03-04 23:00 466

Lunit Announces Partnership to Incorporate its Chest Detection Suite into Philips' Diagnostic X-ray Suite

SEOUL, South Korea, March 4, 2021 /PRNewswire/ -- Lunit , a leading medical AI startup, today announced its partnership withPhilips . Announced during the  European Congress of Radiology (ECR)

2021-03-04 17:00 514

Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service

IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...

2021-03-04 14:33 541

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sust...

2021-03-04 09:00 670

Medical expert warns thousands could die from HPV programming interrupted by Covid-19

LONDON, March 4, 2021 /PRNewswire/ -- On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also c...

2021-03-04 08:01 622

Founder of NutriBullet®* Launches Wellness Brand - Beast Health™ - and its Design-Forward Blender and Hydration System

Groundbreaking Product is First of Several Planned Launches from Beast Health, LLC LOS ANGELES, March 3, 2021 /PRNewswire/ -- Colin Sapire, founder of the NutriBullet®* and innovator behind personal blending products for more than a decade, announces the launch of wellness brand Beast Healt...

2021-03-03 23:02 808

WellmarkerBio receives approval for Phase I clinical trial from the Australian Therapeutic Goods Administration

SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Wellmarker Bio(www.wmbio.co ) announced that on February 23, 2021 the company received approval from the Australian Therapeutic Goods Administration (TGA) for a Phase I clinical trial using WM-S1-030, a targeted anti-cancer d...

2021-03-03 22:00 721

Yuyu Pharma Publishes History for 80th Anniversary

SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Yuyu Pharma (KRX: 000220, CEO Robert Wonsang Yu), in anticipation of the 80th anniversary of its establishment onFebruary 28th, 2021, published its history of challenges and changes over the past 80 years. The history is told in storytelling forma...

2021-03-03 22:00 631

I-Mab to Report Financial Results for the Full Year 2020 and Provide Corporate Update on March 29, 2021

SHANGHAI and GAITHERSBURG, Md., March 3, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the full year ...

2021-03-03 21:00 2283

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility

WUXI, China, March 3, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the European Medicines Agency (EMA) has completed a remote Pre-Approval Inspection (PAI) on its drug substance facility ...

2021-03-03 18:23 451

SciClone Pharmaceuticals Officially Listed on the Main Board of the Hong Kong Stock Exchange

SHANGHAI, March 3, 2021 /PRNewswire/ -- SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" or "SciClone") was officially listed today on the Main Board of The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange" or "HKEx") under stock code: 6600. In the initial of...

2021-03-03 16:43 2510

AXA extends holistic wellness platform "AXA BetterMe" to all Employee Benefits customers

HONG KONG, March 3, 2021 /PRNewswire/ -- With COVID vaccination becoming available inHong Kong, many corporates are getting ready to accelerate their business activities again. As a leading Employee Benefits insurer inHong Kong, AXA Hong Kong andMacau has already taken the lead to support its Emp...

2021-03-03 14:15 722

Biotheus Announces the Closing of a New Round of Financing co-led by General Atlantic and IDG Capital

ZHUHAI, China, March 2, 2021 /PRNewswire/ -- Biotheus has announced the successful completion of a fourth round of financing, co-led by General Atlantic, a leading global growth equity investor, and IDG Capital, a global leading investment firm. Other new investors include Kunlun Capital, CPE, an...

2021-03-03 11:37 719

CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project

SUZHOU, China, March 2, 2021 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc ("CMAB") congratulates its partner Innovent Biologics, Inc ("Innovent") (1801.HK) on the U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for its antibody candidate which ta...

2021-03-03 11:12 556

Telemedicine platform HiDoc launches Nectar, a community app dedicated to women's health and wellness

* Following a spike in the number of teleconsultations and enquiries from the women's community during the circuit breaker period, HiDoc created Nectar, a web-based application to inspire a new generation of women to achieve optimal health * Prominent features of the app include Nectar's Ask ...

2021-03-03 10:00 771

Seegene's Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants

* Seegene's new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 minutes * Seegene's proprietary high multiplex technology enables detection of 10 different targets * S. Korean firm to research additional versions of variant diagnostic tests SEOUL, South Korea,...

2021-03-03 09:20 737

e-condLIFE: Cost of human life and business shut down can be minimized with this new prevention technology

* A smarter preventative way to keep family members safe * Peace of mind for staff and customers that the premises are being disinfected 24 hours KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Since launching inJune 2020, e-condLIFE has been well received and proven to be effective. Dr...

2021-03-03 09:00 841

FWD Group completes investment in BRI Life Indonesia

JAKARTA, Indonesia, March 3, 2021 /PRNewswire/ -- FWD Group ("FWD") today announced that it has completed its investment in a significant minority stake in PT Asuransi BRI Life ("BRI Life"), the life insurance arm of PT Bank Rakyat Indonesia (Persero) Tbk ("BRI"). As part of this investment, BRI ...

2021-03-03 08:25 920

CxSYS Boosts Malaysian Healthcare with Innovative EHR Solutions

KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Malaysia-based CxSYS, managed by Starsoft Systems Sdn Bhd, is boosting the country's healthcare by providing innovative record management solutions with connectivity to a wide range of medical devices, enabling efficient operations and better ...

2021-03-03 08:00 727
12345 ... 981